Related references
Note: Only part of the references are listed.Autophagy in the diabetic heart: A potential pharmacotherapeutic target in diabetic cardiomyopathy
Saikat Dewanjee et al.
AGEING RESEARCH REVIEWS (2021)
Cardiomyopathy in obesity, insulin resistance and diabetes
Michinari Nakamura et al.
JOURNAL OF PHYSIOLOGY-LONDON (2020)
Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
M. Arow et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Pouya Saeedi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential
Isabel R. Schlaepfer et al.
ENDOCRINOLOGY (2020)
Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors JACC State-of-the-Art Review
Thomas A. Zelniker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence
Yi Tan et al.
NATURE REVIEWS CARDIOLOGY (2020)
Empagliflozin modulates renal sympathetic and heart rate baroreflexes in a rabbit model of diabetes
Cindy Gueguen et al.
DIABETOLOGIA (2020)
Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy
Naranjan S. Dhalla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Understanding the distinct subcellular trafficking of CD36 and GLUT4 during the development of myocardial insulin resistance
Joost J. F. P. Luiken et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
The Mitochondria: A Target of Polyphenols in the Treatment of Diabetic Cardiomyopathy
Humna Bhagani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Disruption of energy utilization in diabetic cardiomyopathy; a mini review
Shinsuke Nirengi et al.
CURRENT OPINION IN PHARMACOLOGY (2020)
Comparative Study of the Effects of GLP1 Analog and SGLT2 Inhibitor against Diabetic Cardiomyopathy in Type 2 Diabetic Rats: Possible Underlying Mechanisms
Abdelaziz M. Hussein et al.
BIOMEDICINES (2020)
Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry
Felix Mahfoud et al.
EUROPEAN HEART JOURNAL (2019)
EPHB6 controls catecholamine biosynthesis by up-regulating tyrosine hydroxylase transcription in adrenal gland chromaffin cells
Wei Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats
Hsiang-Chun Lee et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Ketone body can be a fuel substrate for failing heart
Michinari Nakamura et al.
CARDIOVASCULAR RESEARCH (2019)
Heart Failure in Type 2 Diabetes Mellitus Impact of Glucose-Lowering Agents, Heart Failure Therapies, and Novel Therapeutic Strategies
Helena C. Kenny et al.
CIRCULATION RESEARCH (2019)
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Yan Zheng et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking
E. Ramirez et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Renal Denervation Effects on Myocardial Fibrosis and Ventricular Arrhythmias in Rats with Ischemic Cardiomyopathy
Bin Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Role of the Pyruvate Dehydrogenase Complex in Metabolic Remodeling: Differential Pyruvate Dehydrogenase Complex Functions in Metabolism
Sungmi Park et al.
DIABETES & METABOLISM JOURNAL (2018)
Renal Denervation Prevents Heart Failure Progression Via Inhibition of the Renin-Angiotensin System
Thomas E. Sharp et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Chronic O-GlcNAcylation and Diabetic Cardiomyopathy: The Bitterness of Glucose
Simon Ducheix et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2
Vance B. Matthews et al.
JOURNAL OF HYPERTENSION (2017)
Renal Sympathetic Denervation Protects the Failing Heart Via Inhibition of Neprilysin Activity in the Kidney
David J. Polhemus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
The effect of empagliflozin on muscle sympathetic nerve activity in patients with type II diabetes mellitus
Jens Jordan et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2017)
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
K. Ogurtsova et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy
Giacomo Frati et al.
CARDIOVASCULAR RESEARCH (2017)
Metabolic remodelling in diabetic cardiomyopathy
Cher-Rin Chong et al.
CARDIOVASCULAR RESEARCH (2017)
CV Protection in the EMPA-REG OUTCOME Trial: A Thrifty Substrate Hypothesis
Ele Ferrannini et al.
DIABETES CARE (2016)
Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities
Ilaria Russo et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Role of the renal sympathetic nerve in renal glucose metabolism during the development of type 2 diabetes in rats
Kazi Rafiq et al.
DIABETOLOGIA (2015)
Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart
Toan Pham et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
Structure-Function of CD36 and Importance of Fatty Acid Signal Transduction in Fat Metabolism
Marta Yanina Pepino et al.
ANNUAL REVIEW OF NUTRITION, VOL 34 (2014)
A Controlled Trial of Renal Denervation for Resistant Hypertension
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Duodenal-Jejunal Bypass Improves Glycemia and Decreases SGLT1-Mediated Glucose Absorption in Rats With Streptozotocin-Induced Type 2 Diabetes
Christian Ferdinand Jurowich et al.
ANNALS OF SURGERY (2013)
Decreased Autophagy in Rat Heart Induced by Anti-β1-Adrenergic Receptor Autoantibodies Contributes to the Decline in Mitochondrial Membrane Potential
Li Wang et al.
PLOS ONE (2013)
The human sympathetic nervous system: its relevance in hypertension and heart failure
Gianfranco Parati et al.
EUROPEAN HEART JOURNAL (2012)
A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart
Mark A. Cole et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Lipotoxicity in type 2 diabetic cardiomyopathy
Tineke van de Weijer et al.
CARDIOVASCULAR RESEARCH (2011)
Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension A Pilot Study
Felix Mahfoud et al.
CIRCULATION (2011)
Analgesic effects of tramadol, carprofen or multimodal analgesia in rats undergoing ventral laparotomy
Coralie Zegre Cannon et al.
LAB ANIMAL (2011)
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
Murray D. Esler et al.
LANCET (2010)
Increased Enzymatic O-GlcNAcylation of Mitochondrial Proteins Impairs Mitochondrial Function in Cardiac Myocytes Exposed to High Glucose
Yong Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Share Paper
